Source BioScience

Investment date September 2016
Location Nottingham, UK
Sector Life sciences
Deal type Public-to-private
Approximate turnover £26 million

Investment overview

Source Bioscience provides laboratory services and products to the healthcare and clinical, life science research and biopharma industries. Services include diagnostic testing for cancer and other infectious disease, DNA sequencing and contract research activities, cryostorage and stability testing. Products include serology products for blood and tissue banking, life science research reagents and controlled environment chambers. Source BioScience operates ten facilities across the UK, Ireland, Germany and the US and has customers in over 90 countries.